BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24801505)

  • 1. NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression.
    Grabowska MM; Elliott AD; DeGraff DJ; Anderson PD; Anumanthan G; Yamashita H; Sun Q; Friedman DB; Hachey DL; Yu X; Sheehan JH; Ahn JM; Raj GV; Piston DW; Gronostajski RM; Matusik RJ
    Mol Endocrinol; 2014 Jun; 28(6):949-64. PubMed ID: 24801505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia.
    Grabowska MM; Kelly SM; Reese AL; Cates JM; Case TC; Zhang J; DeGraff DJ; Strand DW; Miller NL; Clark PE; Hayward SW; Gronostajski RM; Anderson PD; Matusik RJ
    Endocrinology; 2016 Mar; 157(3):1094-109. PubMed ID: 26677878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially.
    Yu X; Gupta A; Wang Y; Suzuki K; Mirosevich J; Orgebin-Crist MC; Matusik RJ
    Ann N Y Acad Sci; 2005 Dec; 1061():77-93. PubMed ID: 16467259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upstream stimulatory factor 2, a novel FoxA1-interacting protein, is involved in prostate-specific gene expression.
    Sun Q; Yu X; Degraff DJ; Matusik RJ
    Mol Endocrinol; 2009 Dec; 23(12):2038-47. PubMed ID: 19846536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear mobility and activity of FOXA1 with androgen receptor are regulated by SUMOylation.
    Sutinen P; Rahkama V; Rytinki M; Palvimo JJ
    Mol Endocrinol; 2014 Oct; 28(10):1719-28. PubMed ID: 25127374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes.
    Gao N; Zhang J; Rao MA; Case TC; Mirosevich J; Wang Y; Jin R; Gupta A; Rennie PS; Matusik RJ
    Mol Endocrinol; 2003 Aug; 17(8):1484-507. PubMed ID: 12750453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
    Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
    Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer.
    Sahu B; Laakso M; Ovaska K; Mirtti T; Lundin J; Rannikko A; Sankila A; Turunen JP; Lundin M; Konsti J; Vesterinen T; Nordling S; Kallioniemi O; Hautaniemi S; Jänne OA
    EMBO J; 2011 Sep; 30(19):3962-76. PubMed ID: 21915096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific pioneer factors associate with androgen receptor cistromes and transcription programs.
    Pihlajamaa P; Sahu B; Lyly L; Aittomäki V; Hautaniemi S; Jänne OA
    EMBO J; 2014 Feb; 33(4):312-26. PubMed ID: 24451200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype.
    Robinson JL; Hickey TE; Warren AY; Vowler SL; Carroll T; Lamb AD; Papoutsoglou N; Neal DE; Tilley WD; Carroll JS
    Oncogene; 2014 Dec; 33(50):5666-74. PubMed ID: 24292680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor I transcription factors regulate IGF binding protein 5 gene transcription in human osteoblasts.
    Pérez-Casellas LA; Wang X; Howard KD; Rehage MW; Strong DD; Linkhart TA
    Biochim Biophys Acta; 2009 Feb; 1789(2):78-87. PubMed ID: 18809517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor I regulates brain fatty acid-binding protein and glial fibrillary acidic protein gene expression in malignant glioma cell lines.
    Brun M; Coles JE; Monckton EA; Glubrecht DD; Bisgrove D; Godbout R
    J Mol Biol; 2009 Aug; 391(2):282-300. PubMed ID: 19540848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.
    Tan PY; Chang CW; Chng KR; Wansa KD; Sung WK; Cheung E
    Mol Cell Biol; 2012 Jan; 32(2):399-414. PubMed ID: 22083957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation.
    Baumgart SJ; Nevedomskaya E; Lesche R; Newman R; Mumberg D; Haendler B
    Mol Oncol; 2020 Sep; 14(9):2022-2039. PubMed ID: 32333502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program.
    Jin HJ; Zhao JC; Wu L; Kim J; Yu J
    Nat Commun; 2014 May; 5():3972. PubMed ID: 24875621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer.
    Wu D; Sunkel B; Chen Z; Liu X; Ye Z; Li Q; Grenade C; Ke J; Zhang C; Chen H; Nephew KP; Huang TH; Liu Z; Jin VX; Wang Q
    Nucleic Acids Res; 2014 Apr; 42(6):3607-22. PubMed ID: 24423874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global mapping of cell type-specific open chromatin by FAIRE-seq reveals the regulatory role of the NFI family in adipocyte differentiation.
    Waki H; Nakamura M; Yamauchi T; Wakabayashi K; Yu J; Hirose-Yotsuya L; Take K; Sun W; Iwabu M; Okada-Iwabu M; Fujita T; Aoyama T; Tsutsumi S; Ueki K; Kodama T; Sakai J; Aburatani H; Kadowaki T
    PLoS Genet; 2011 Oct; 7(10):e1002311. PubMed ID: 22028663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioneer of prostate cancer: past, present and the future of FOXA1.
    Teng M; Zhou S; Cai C; Lupien M; He HH
    Protein Cell; 2021 Jan; 12(1):29-38. PubMed ID: 32946061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression.
    Zhao JC; Fong KW; Jin HJ; Yang YA; Kim J; Yu J
    Oncogene; 2016 Aug; 35(33):4335-44. PubMed ID: 26751772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Factor I Represses the Notch Effector HEY1 in Glioblastoma.
    Brun M; Jain S; Monckton EA; Godbout R
    Neoplasia; 2018 Oct; 20(10):1023-1037. PubMed ID: 30195713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.